Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Alzheimer's Disease”

855 trials

Showing 20 of 855 results

Not applicableStudy completedNCT00954616
What this trial is testing

Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly

Who this might be right for
Alzheimer's Disease
University Hospital, Limoges 636
Not applicableNot Yet RecruitingNCT07230158
What this trial is testing

Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease II (TRANSFORM-AD II)

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 160
Large-scale testing (Phase 3)Study completedNCT01872598
What this trial is testing

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AB Science 721
Testing effectiveness (Phase 2)Study completedNCT02240693
What this trial is testing

Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 128
Not applicableStudy completedNCT05015478
What this trial is testing

Rhythmic Light Therapy for Alzheimer's Disease Patients

Who this might be right for
Mild Cognitive Impairment
Icahn School of Medicine at Mount Sinai 52
Testing effectiveness (Phase 2)Study completedNCT00501111
What this trial is testing

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AstraZeneca 659
Testing effectiveness (Phase 2)Study completedNCT01083316
What this trial is testing

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 35
Large-scale testing (Phase 3)Ended earlyNCT04464564
What this trial is testing

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 241
Not applicableStudy completedNCT04496778
What this trial is testing

Low Level Laser Therapy Impact on Cognitive Function and Quality of Life in Alzheimer Anemic Elderly Patients

Who this might be right for
Alzheimer DiseaseCognitive Impairment, Mild
Cairo University 60
Testing effectiveness (Phase 2)Study completedNCT01439555
What this trial is testing

Endothelial Facilitation in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University of Massachusetts, Worcester 11
Post-approval studies (Phase 4)Study completedNCT00260624
What this trial is testing

Escitalopram Treatment of Patients With Agitated Dementia

Who this might be right for
Alzheimer's DiseasePsychomotor Agitation
University of Rochester 20
Large-scale testing (Phase 3)Ended earlyNCT00380276
What this trial is testing

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Who this might be right for
Alzheimer's Disease
Myrexis Inc. 1,000
Testing effectiveness (Phase 2)UnknownNCT01547689
What this trial is testing

Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT02756858
What this trial is testing

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 21
Testing effectiveness (Phase 2)Study completedNCT04070378
What this trial is testing

Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Marc L Gordon, MD 16
Not applicableStudy completedNCT01009476
What this trial is testing

Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine

Who this might be right for
DementiaAlzheimer DiseaseDementia, Vascular
Janssen-Cilag G.m.b.H 1,134
Very early researchStudy completedNCT01024660
What this trial is testing

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

Who this might be right for
Alzheimer's Disease
AstraZeneca 155
Not applicableStudy completedNCT00029120
What this trial is testing

Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder

Who this might be right for
Alzheimer DiseaseDementiaMemory Disorder+1 more
National Institute of Mental Health (NIMH) 450
Testing effectiveness (Phase 2)Study completedNCT00515333
What this trial is testing

TRx0014 in Patients With Mild or Moderate Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
TauRx Therapeutics Ltd 323
Large-scale testing (Phase 3)Ended earlyNCT00996918
What this trial is testing

A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 198
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation